News Announcement

Advanced Enzyme Technologies: Outcome Of Board Meeting

With reference to the Board meeting notice dated February 02 2021 we hereby inform that the Board of Directors in its meeting held on February 12 2021 has inter-alia approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31 2020.

In view of the aforesaid we hereby enclose the following:
Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31 2020 along with the Limited Review Report issued by B S R & Co. LLP Statutory Auditors of the Company.
Press Release and Earnings Presentation for the quarter and nine months ended December 31 2020.
Allotted 4 500 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme 2015.

This is for your information and for public at large.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.